InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
LPS-EB (LPS from E. coli O111:B4) | Characterizing the genetic basis of innate immune response in TLR4-activated ... | 2014 | Nat Commun. | Kim S. et al. | DOI: 10.1038/ncomms6236 |
ODN 1826 VacciGrade™ | Gold nanoparticle-M2e conjugate coformulated with CpG induces protective immu... | 2014 | Nanomedicine (Lond). 2 | Tao W. et al. | DOI: 10.2217/nnm.13.58 |
IL-1α & IL-1β Reporter HEK 293 Cells | Pathogen-Mediated Inhibition of Anorexia Promotes Host Survival and Transmiss... | 2017 | Cell. | Rao S. et al. | DOI: 10.1016/j.cell.2017.01.006 |
Plasmocin® - Mycoplasma Elimination Reagent | DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia v... | 2016 | Nat Med. | Guryanova OA. et al. | DOI: 10.1038/nm.4210 |
THP1-Dual™ KO-STING Cells | Investigations on the molecular mode of action of the novel immunostimulator ... | 2017 | Mol Immunol. | Ilg T. | DOI: 10.1016/j.molimm.2017.07.013 |
iE-DAP | Identification of Selective Small Molecule Inhibitors of the Nucleotide-Bindi... | 2014 | PLoS One | Rickard D.J. et al. | DOI: 10.1371/journal.pone.0096737 |
ODN 2395 VacciGrade™ | Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of pla... | 2017 | J Thromb Haemost. | Delierneux C. et al. | DOI: 10.1111/jth.13669 |
293/TLR4-MD2-CD14 | Raftlin Controls Lipopolysaccharide-Induced TLR4 Internalization and TICAM-1 ... | 2016 | J Immunol. | Tatematsu M. et al. | DOI: 10.4049/jimmunol.1501734 |
pSELECT-GFPzeo | Cytomegalovirus (CMV) Epitope-Specific CD4+ T Cells Are Inflated in HIV+ CMV+... | 2017 | J Immunol. | Abana C.O. et al. | DOI: 10.4049/jimmunol.1700851 |
CL097 | K+ Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Target... | 2016 | Immunity. | Groß C.J. et al. | DOI: 10.1016/j.immuni.2016.08.010 |
G418 (Geneticin) | Treatment with Caffeic Acid and Resveratrol Alleviates Oxidative Stress Induc... | 2017 | Sci Rep. | Wu Y.L. et al. | DOI: 10.1038/s41598-017-11839-0 |
ODN 2395 - TLR9 ligand | Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery. | 2012 | PNAS | Nguyen D.N. et al. | DOI: 10.1073/pnas.1121423109 |
THP1-Blue™ ISG Cells | Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy. | 2017 | Nanomedicine. | Wilson DR. et al. | DOI: 10.1016/j.nano.2017.10.013 |
ODN TTAGGG (A151) | Phosphorothioate backbone modifications of nucleotide-based drugs are potent ... | 2015 | J Exp Med. | Flierl U. et al. | DOI: 10.1084/jem.20140391 |
IFN-α/β Reporter HEK 293 Cells | IFI16 is required for DNA sensing in human macrophages by promoting productio... | 2017 | Nat Commun. | Jønsson K.L. et al. | DOI: 10.1038/ncomms14391 |
FSL-1 | Induction of Indoleamine 2, 3-dioxygenase by Pre-treatment with Poly (I: C) M... | 2016 | Immune Netw. | Ryu D.B. et al. | DOI: 10.4110/in.2016.16.6.358 |
Human TLR4 Reporter HEK293 Cells (NF-κB) | Vaccine nanocarriers: Coupling intracellular pathways and cellular biodistrib... | 2017 | Biomaterials. | Rincon-Restrepo M. et al. | DOI: 10.1016/j.biomaterials.2017.03.047 |
Pepinh-MYD | ] The Heparanase Inhibitor PG545 Attenuates Colon Cancer Initiation and Growt... | 2017 | Neoplasia. | Singh P. et al. | DOI: 10.1016/j.neo.2016.12.001 |
LPS-PG (Lipopolysaccharide from P. gingivalis) | Compromised inflammatory cytokine response to P. gingivalis LPS by fibroblast... | 2017 | Clin Oral Investig. | Fitzsimmons T.R. et al. | DOI: 10.1007/s00784-017-2171-6 |
R848 (Resiquimod) | T-box transcription factor T-bet, a key player in a unique type of B-cell act... | 2013 | PNAS | Rubtsova K. et al. | DOI: 10.1073/pnas.1312348110 |